Natural xanthones as α-Mangostin induce vasorelaxation involving key gating residues in the S6 domain of BK channels.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42089408.
- Also identified by DOI 10.7554/eLife.109479 and PMC identifier 13148824.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Polyphenolic compounds are widely explored for health benefits, including hypertension, but their active ingredients, molecular targets, and mechanisms remain poorly defined. We identify the xanthone Mangostin from <i>Garcinia mangostana</i> as a potent modulator of several potassium channels, with large-conductance K<sup>+</sup> (BK) channels as its primary target for vasorelaxation. Mangostin-activated BK channels as α subunits alone, in complexes with vascular β1 subunits, and in reconstituted BKα/β1-Ca<sub>v</sub> nanodomains. It shifted BK voltage activation to more negative potentials by antagonizing channel closure and promoting channel opening without markedly altering Ca²<sup>+</sup> sensitivity. Docking, competition, single-channel analysis, and mutagenesis localized the binding site in the pore cavity below the SF, involving gating-critical S6 residues I308, L312, and A316, and suggest that Mangostin stays bound in closed and open states. These findings establish BK channel activation as the core molecular mechanism driving Mangostin's vascular effects and define its structural mode of action, informing nutraceutical safety assessment and BK-targeted drug design.
Medical subject headings
- Xanthones
- Large-Conductance Calcium-Activated Potassium Channels
- Vasodilation
- Ion Channel Gating
- Vasodilator Agents